This inventor holds 2 USPTO granted patents and 5 published patent applications and 6 EPO patents. Top assignees: Institut Du Cerveau Et De La Moelle Epiniere, Assistance Publique-Hopitaux De Paris, Centre National De La Recherche Scientifique. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:




Years Active: 2020-2026
Title: The Innovative Contributions of Patrick Michel
Introduction
Patrick Michel is a notable inventor based in Paris, France. He has made significant contributions to the field of neurodegenerative disorder treatments through his innovative research and development of pharmaceutical compounds.
Latest Patents
Michel holds a patent for "1, 4, 8-triazaphenanthrene derivatives for the treatment of neurodegenerative disorders." This invention relates to compounds of formula (I), particularly for their use as a medicament, especially in the treatment or prevention of neurodegenerative disorders. The invention also encompasses methods for producing these compounds and the pharmaceutical compositions containing them. He has 1 patent to his name.
Career Highlights
Throughout his career, Patrick Michel has worked with esteemed institutions such as the National Institute of Health and Medical Research and Université Paris-Sud. His work has focused on advancing medical treatments and understanding the complexities of neurodegenerative diseases.
Collaborations
Michel has collaborated with notable colleagues, including Rita Raisman-Vozari and Gael Le Douaron. Their combined expertise has contributed to the advancement of research in their field.
Conclusion
Patrick Michel's innovative work in developing treatments for neurodegenerative disorders highlights his significant role in the medical research community. His contributions continue to pave the way for future advancements in this critical area of health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile